Barbara Yeung

1.5k total citations
28 papers, 808 citations indexed

About

Barbara Yeung is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Barbara Yeung has authored 28 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 21 papers in Hepatology and 8 papers in Infectious Diseases. Recurrent topics in Barbara Yeung's work include Hepatitis C virus research (21 papers), Liver Disease Diagnosis and Treatment (12 papers) and Hepatitis B Virus Studies (12 papers). Barbara Yeung is often cited by papers focused on Hepatitis C virus research (21 papers), Liver Disease Diagnosis and Treatment (12 papers) and Hepatitis B Virus Studies (12 papers). Barbara Yeung collaborates with scholars based in Australia, Canada and United States. Barbara Yeung's co-authors include Margaret Hellard, John Kaldor, Andrew R. Lloyd, Gregory J. Dore, Gail Matthews, Jason Grebely, William D. Rawlinson, Kathy Petoumenos, Peter A. White and Paul Haber and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Barbara Yeung

28 papers receiving 781 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Yeung Australia 16 639 608 228 74 60 28 808
David Vlahov United States 7 803 1.3× 875 1.4× 321 1.4× 46 0.6× 72 1.2× 8 1.1k
Laura S. Diamondstone United States 6 324 0.5× 317 0.5× 173 0.8× 15 0.2× 32 0.5× 7 528
Agnieszka Bednarska Poland 7 174 0.3× 184 0.3× 67 0.3× 37 0.5× 23 0.4× 20 282
Emma Page United Kingdom 11 246 0.4× 258 0.4× 133 0.6× 9 0.1× 53 0.9× 16 379
S Bevilacqua France 9 199 0.3× 333 0.5× 249 1.1× 10 0.1× 23 0.4× 15 616
Xien Gui China 15 165 0.3× 346 0.6× 234 1.0× 7 0.1× 75 1.3× 33 562
S Echevarrı́a Spain 11 150 0.2× 198 0.3× 118 0.5× 14 0.2× 25 0.4× 30 381
Clement Gascua Adu-Gyamfi South Africa 10 130 0.2× 203 0.3× 177 0.8× 3 0.0× 14 0.2× 17 413
Catherine Dhiver France 8 95 0.1× 116 0.2× 307 1.3× 10 0.1× 46 0.8× 10 570
Maria Luisa Muggiasca Italy 7 135 0.2× 195 0.3× 155 0.7× 26 0.4× 12 0.2× 13 359

Countries citing papers authored by Barbara Yeung

Since Specialization
Citations

This map shows the geographic impact of Barbara Yeung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Yeung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Yeung more than expected).

Fields of papers citing papers by Barbara Yeung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Yeung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Yeung. The network helps show where Barbara Yeung may publish in the future.

Co-authorship network of co-authors of Barbara Yeung

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Yeung. A scholar is included among the top collaborators of Barbara Yeung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Yeung. Barbara Yeung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chan, Curtis, Douglas Fraser, Stefanie Vaccher, et al.. (2021). Overcoming barriers to HIV pre-exposure prophylaxis (PrEP) coverage in Australia among Medicare-ineligible people at risk of HIV: results from the MI-EPIC clinical trial. Sexual Health. 18(6). 453–459. 15 indexed citations
3.
Bavinton, Benjamin R., Stefanie Vaccher, Fengyi Jin, et al.. (2021). High Levels of Prevention-Effective Adherence to HIV PrEP: An Analysis of Substudy Data From the EPIC-NSW Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. 87(4). 1040–1047. 16 indexed citations
4.
McManus, Hamish, Andrew E. Grulich, Janaki Amin, et al.. (2020). Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men. JAMA Network Open. 3(12). e2030806–e2030806. 27 indexed citations
5.
Alavi, Maryam, Tim Spelman, Gail Matthews, et al.. (2015). Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C. International Journal of Drug Policy. 26(10). 976–983. 32 indexed citations
6.
Martinello, Marianne, Margaret Hellard, David Shaw, et al.. (2014). Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II Study. Hepatology. 60. 1 indexed citations
7.
Grebely, Jason, Jordan J. Feld, Tanya Applegate, et al.. (2013). Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection. Hepatology. 57(6). 2124–2134. 58 indexed citations
8.
Flynn, Jacqueline K., Gregory J. Dore, Margaret Hellard, et al.. (2013). Maintenance of Th1 hepatitis C virus (HCV)‐specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment. Journal of Gastroenterology and Hepatology. 28(11). 1770–1781. 17 indexed citations
9.
Feld, Jordan J., Jason Grebely, Gail Matthews, et al.. (2013). Plasma Interferon-Gamma-Inducible Protein-10 Levels Are Associated with Early, but Not Sustained Virological Response during Treatment of Acute or Early Chronic HCV Infection. PLoS ONE. 8(11). e80003–e80003. 12 indexed citations
10.
Alavi, Maryam, Jason Grebely, Gail Matthews, et al.. (2012). Effect of pegylated interferon-alpha-2a treatment on mental health during recent hepatitis C virus infection. Hepatology. 27(5). 5 indexed citations
11.
Flynn, Jacqueline K., Gregory J. Dore, Gail Matthews, et al.. (2012). Impaired Hepatitis C Virus (HCV)–Specific Interferon-γ Responses in Individuals With HIV Who Acquire HCV Infection: Correlation With CD4+ T-Cell Counts. The Journal of Infectious Diseases. 206(10). 1568–1576. 19 indexed citations
12.
Grebely, Jason, Margaret Hellard, Tanya Applegate, et al.. (2012). Virological responses during treatment for recent hepatitis C virus. AIDS. 26(13). 1653–1661. 18 indexed citations
13.
Grebely, Jason, Son Pham, Gail Matthews, et al.. (2011). Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection. Hepatology. 55(4). 1058–1069. 70 indexed citations
14.
Alavi, Maryam, Jason Grebely, Gail Matthews, et al.. (2011). Effect of pegylated interferon‐α‐2a treatment on mental health during recent hepatitis C virus infection. Journal of Gastroenterology and Hepatology. 27(5). 957–965. 37 indexed citations
15.
Grebely, Jason, Gail Matthews, Margaret Hellard, et al.. (2010). Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users. Journal of Hepatology. 55(1). 76–85. 46 indexed citations
16.
Flynn, Jacqueline K., Gregory J. Dore, Margaret Hellard, et al.. (2010). Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users. Journal of Viral Hepatitis. 18(8). 549–561. 51 indexed citations
17.
Grebely, Jason, Kathy Petoumenos, Margaret Hellard, et al.. (2010). Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection. Hepatology. 52(4). 1216–1224. 138 indexed citations
18.
Matthews, Gail, Jason Grebely, Margaret Hellard, et al.. (2010). 60 DIFFERENCES IN EARLY VIROLOGICAL DECLINE IN INDIVIDUALS TREATED WITHIN THE AUSTRALIAN TRIAL IN ACUTE HCV SUGGEST A POTENTIAL BENEFIT FOR THE USE OF RIBAVIRIN. Journal of Hepatology. 52. S28–S28. 4 indexed citations
19.
Dore, Gregory J., Margaret Hellard, Gail Matthews, et al.. (2009). Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection. Gastroenterology. 138(1). 123–135.e2. 115 indexed citations
20.
Matthews, Gail, Margaret Hellard, Paul Haber, et al.. (2009). Characteristics and Treatment Outcomes among HIV‐Infected Individuals in the Australian Trial in Acute Hepatitis C. Clinical Infectious Diseases. 48(5). 650–658. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Vlahov Breakdown of academic impact, for papers by Laura S. Diamondstone Breakdown of academic impact, for papers by Agnieszka Bednarska Breakdown of academic impact, for papers by Emma Page Breakdown of academic impact, for papers by S Bevilacqua Breakdown of academic impact, for papers by Xien Gui Breakdown of academic impact, for papers by S Echevarrı́a Breakdown of academic impact, for papers by Clement Gascua Adu-Gyamfi Breakdown of academic impact, for papers by Catherine Dhiver Breakdown of academic impact, for papers by Maria Luisa Muggiasca
Rankless by CCL
2026